Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April N Abbott

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Infection and Immunity|October 4, 2006
Identification of potential virulence determinants by Himar1 transposition of infectious Borrelia burgdorferi B31Douglas J Botkin, April N Abbott, Philip E Stewart, et al.
Journal of Clinical Microbiology|October 12, 2023
Reply to "Letter responding to performance of updated <i>Enterobacterales</i> piperacillin-tazobactam breakpoints on the MicroScan antimicrobial susceptibility testing system"Romney M Humphries, April N Abbott, Kevin Alby, et al.
Journal of Clinical Microbiology|January 23, 2015
Human Diphyllobothrium nihonkaiense infection in Washington StateFerric C Fang, Zachary P Billman, Carolyn K Wallis, et al.
Journal of Clinical Microbiology|June 21, 2024
Defining the value of medical microbiology consultationKyle G Rodino, Paul M Luethy, April N Abbott, et al.
Microbiology (Reading, England)|June 6, 2008
A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous responseKerry J Welsh, April N Abbott, Shen-An Hwang, et al.
Neuroimmunomodulation|March 11, 2011
IL-6 mediates 11βHSD type 2 to effect progression of the mycobacterial cord factor trehalose 6,6'-dimycolate-induced granulomatous responseApril N Abbott, Kerry J Welsh, Shen-An Hwang, et al.
Journal of Clinical Microbiology|January 22, 2010
Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycinKerry J Welsh, April N Abbott, Evan M Lewis, et al.
Journal of Clinical Microbiology|February 28, 2014
Coinfection of Fusobacterium nucleatum and Actinomyces israelii in mastoiditis diagnosed by next-generation DNA sequencingStephen J Salipante, Daniel R Hoogestraat, April N Abbott, et al.
Journal of Clinical Microbiology|August 26, 2011
Predictors of relapse of methicillin-resistant Staphylococcus aureus bacteremia after treatment with vancomycinKerry J Welsh, Kimberly A Skrobarcek, April N Abbott, et al.
Diagnostic Microbiology and Infectious Disease|September 21, 2016
Incidental identification of Strongyloides stercoralis infection by broad-range 28S rDNA gene sequencing in a patient with a hematolymphoid malignancyEric Q Konnick, Siu-Kei Chow, Nicholas P Reder, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Infection and Immunity|October 4, 2006
Identification of potential virulence determinants by Himar1 transposition of infectious Borrelia burgdorferi B31Douglas J Botkin, April N Abbott, Philip E Stewart, et al.
Journal of Clinical Microbiology|October 12, 2023
Reply to "Letter responding to performance of updated <i>Enterobacterales</i> piperacillin-tazobactam breakpoints on the MicroScan antimicrobial susceptibility testing system"Romney M Humphries, April N Abbott, Kevin Alby, et al.
Journal of Clinical Microbiology|January 23, 2015
Human Diphyllobothrium nihonkaiense infection in Washington StateFerric C Fang, Zachary P Billman, Carolyn K Wallis, et al.
Journal of Clinical Microbiology|June 21, 2024
Defining the value of medical microbiology consultationKyle G Rodino, Paul M Luethy, April N Abbott, et al.
Microbiology (Reading, England)|June 6, 2008
A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous responseKerry J Welsh, April N Abbott, Shen-An Hwang, et al.
Neuroimmunomodulation|March 11, 2011
IL-6 mediates 11βHSD type 2 to effect progression of the mycobacterial cord factor trehalose 6,6'-dimycolate-induced granulomatous responseApril N Abbott, Kerry J Welsh, Shen-An Hwang, et al.
Journal of Clinical Microbiology|January 22, 2010
Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycinKerry J Welsh, April N Abbott, Evan M Lewis, et al.
Journal of Clinical Microbiology|February 28, 2014
Coinfection of Fusobacterium nucleatum and Actinomyces israelii in mastoiditis diagnosed by next-generation DNA sequencingStephen J Salipante, Daniel R Hoogestraat, April N Abbott, et al.
Journal of Clinical Microbiology|August 26, 2011
Predictors of relapse of methicillin-resistant Staphylococcus aureus bacteremia after treatment with vancomycinKerry J Welsh, Kimberly A Skrobarcek, April N Abbott, et al.
Diagnostic Microbiology and Infectious Disease|September 21, 2016
Incidental identification of Strongyloides stercoralis infection by broad-range 28S rDNA gene sequencing in a patient with a hematolymphoid malignancyEric Q Konnick, Siu-Kei Chow, Nicholas P Reder, et al.
Pageof 2